Positive

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Positive

ADCs keep showing impressive activity across cancers – Paolo Tarantino

Photo from Paolo Tarantino/Twitter

Jun 28, 2023, 17:38

ADCs keep showing impressive activity across cancers – Paolo Tarantino

ADCs keep showing impressive activity across cancers. 1L EV+pembro led to 64% ORR among patients with advanced urothelial cancer. Still, the 3.9% rate of fatal TRAEs calls for strategies to optimize the toxicities of ADCs, particularly when used in combos.

For details: Click here

Source: Paolo Tarantino/Twitter

ADCs cancer OncoDaily Oncology Paolo Tarantino urothelial cancer

Aug 14, 2024, 10:29

Rahul Banerjee: They say not all MRD negativity in myeloma is created equal

Aug 14, 2024, 10:19

Manchester Cancer Research Centre is hiring for a new Head of Centre Operations and Partnerships for the MCRC

Aug 14, 2024, 10:05

There's no sound sweeter than the ringing of the survivor bell - City of Hope Orange County

Aug 14, 2024, 09:59

Free learning opportunity for radiation oncology residents - Radiation Oncology Institute

Aug 14, 2024, 09:40

Join Lung Policy to find out how to promote change in your area - IASLC

Aug 14, 2024, 09:02

GIAHC - Shoba Krishnan shares insights on cost-effective cancer therapy

Aug 14, 2024, 08:44

Improving cancer care in conflict-impacted populations by Julie Gralow et al - ASCO

Aug 14, 2024, 07:49

New LBCL CNS prophylaxis guidelines by Matt Wilson et al.

Aug 14, 2024, 07:37

Sylvester Comprehensive Cancer Center's 20-week “Believe in You” fitness training program

Aug 14, 2024, 07:35

Elisa Agostinetto: The sub-analysis of the EMERALD trial

Aug 14, 2024, 07:33

Olanzapine as antiemetic prophylaxis in chemotherapy

Aug 14, 2024, 07:30

Developing a mobile app to address the daily challenges of cancer patients and survivors by EU smartCARE